Neurology News

Together Senior Health, a digital therapeutics and cognitive health firm, has announced the launch of its cognitive health platform, which it hopes will reduce the impact of memory loss in those with Alzheimer’s disease and dementia.

SEATTLE — Clinicians should consider disease-modifying therapeutics when treating patients with rare pediatric disorders, according to an expert at the 2022 American Academy of Neurology annual meeting.

Patients with Alzheimer’s disease who are treated with lecanemab have shown the potential to reaccumulate brain amyloid after removal of the drug, a speaker said at the 2022 American Academy of Neurology annual meeting.

SEATTLE – Inebilizumab was shown to be safe and effective in preventing relapses in individuals with neuromyelitis optica spectrum disorder, a speaker said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — MRI biomarkers were significantly associated with glial tau pathology and could aid in the diagnosis of certain neurodegenerative diseases, a presenter said at the 2022 American Academy of Neurology annual meeting.

Women exposed to childhood sexual and emotional abuse had a greater risk for developing multiple sclerosis, according to a prospective cohort study published in the Journal of Neurology, Neurosurgery & Psychiatry.

SEATTLE — Patients with ALS who were treated with CNM-Au8 — a gold nanocrystal suspension — showed improvements in survival, a speaker said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Fentanyl-related cardiac arrest is associated with worse neurological injury and outcomes compared with cardiac arrest from other opioids, according to a presenter at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Black patients with MS demonstrated a higher rate of disability throughout their disease course compared with white MS patients, according to a presenter at the 2022 American Academy of Neurology annual meeting.

Boston Scientific Corp. announced it has received FDA approval for its image-guided software for deep brain stimulation therapy in patients with Parkinson’s disease.